DR. DAVID ROBERT MCDUFF M.D.
Prescription History 1902002124
Psychiatry & Neurology - Addiction Psychiatry in Ellicott City, MD
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. DAVID ROBERT MCDUFF M.D., an active Addiction Psychiatry specialist practicing in Ellicott City, MD. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 39 documented patient claims. Among these therapy options, the most frequently utilized medication is Buprenorphine Hcl, which accounts for 14 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Claims | 30-Day Fills | Days Supply | Cost / Claim | Utilization vs MD Avg |
|---|---|---|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | 14.0 | 420 | $226.45 | ▼ Below Avg. |
Utilization: claims vs the average MD prescriber Averages are among MD prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the MD average Gross Part D cost per claim; not the patient's out-of-pocket price. 14.0 30-Day Fills 420 Days Supply About Buprenorphine-Naloxone: This medication contains 2 medicines: buprenorphine and naloxone. Show more ▾ It is used to treat opioid dependence/addiction. Buprenorphine belongs to a class of drugs called mixed opioid agonist-antagonists. Buprenorphine helps prevent withdrawal symptoms caused by stopping other opioids. Naloxone is an opioid antagonist that blocks the effect of opioids and can cause severe opioid withdrawal when injected. It has little effect when taken by mouth or dissolved under the tongue. It is combined with buprenorphine to prevent abuse and misuse (injection) of this medication. This combination medication is used as part of a complete treatment program for drug abuse (such as compliance monitoring, counseling, behavioral contract, lifestyle changes). Ask your doctor or pharmacist if you should have other forms of naloxone available to treat opioid overdose. Teach your family or household members about the signs of an opioid overdose and how to treat it. | |||||
| Buprenorphine Hcl | 14 | 14.0 | 386 | $15.44▼ below MD avg | ▼ Below Avg. |
Utilization: claims vs the average MD prescriber Averages are among MD prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the MD average This provider's average cost per claim is below the MD average for this medication. 14.0 30-Day Fills 386 Days Supply About Buprenorphine Hcl: Buprenorphine is used to help relieve severe ongoing pain. Show more ▾ Buprenorphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Do not use this medication to relieve pain that is mild or that will go away in a few days. This medication is not for occasional (as needed) use. A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use. | |||||
| Aripiprazole | 11 | 15.0 | 450 | $5.50▼ below MD avg | ▼ Below Avg. |
Utilization: claims vs the average MD prescriber Averages are among MD prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the MD average This provider's average cost per claim is below the MD average for this medication. 15.0 30-Day Fills 450 Days Supply About Aripiprazole: Aripiprazole is used to treat certain mental/mood disorders (such as bipolar disorder, schizophrenia, Tourette's syndrome, and irritability associated with autistic disorder). Show more ▾ It may also be used in combination with other medication to treat depression. Aripiprazole is known as an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural chemicals in the brain (neurotransmitters). This medication can decrease hallucinations and improve your concentration. It helps you to think more clearly and positively about yourself, feel less nervous, and take a more active part in everyday life. Aripiprazole can treat severe mood swings and decrease how often mood swings occur. A piperazine and quinolone derivative that is used primarily as an antipsychotic agent. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as an adjunct therapy for the treatment of depression. | |||||
About this data. The prescription history for DR. DAVID ROBERT MCDUFF M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Addiction Psychiatry prescribing approach at this Ellicott City, MD practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MD prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
